1h Free Analyst Time
The blood plasma market is forecasted to grow by USD 15.89 billion during 2023-2028, accelerating at a CAGR of 8.6% during the forecast period. The report on the blood plasma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by innovative solutions targeting global blood shortage crisis, launch of largest-scale clinical trials, and improved blood safety and availability initiatives.
The blood plasma market is segmented as below:
By Application
- Therapeutic use
- Diagnostic use
- Research and development
By Source
- Human plasma
- Synthetic plasma
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the blood plasma market covers the following areas:
- Blood Plasma Market sizing
- Blood Plasma Market forecast
- Blood Plasma Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Source
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global blood plasma market: ADMA Biologics Inc., Bio Products Laboratory Ltd., Biotest AG, CSL Ltd., GC Biopharma Corp., Grifols SA, Kamada Ltd., Kedrion SpA, LFB SA, Meiji Holdings Co. Ltd., Octapharma AG, Pfizer Inc., Sanquin, SK Plasma Co. Ltd., and Takeda Pharmaceutical Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is expanding use of microbial enzymes in blood transfusion technology."
According to the report, one of the major drivers for this market is the innovative solutions targeting global blood shortage crisis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ADMA Biologics Inc.
- Bio Products Laboratory Ltd.
- Biotest AG
- CSL Ltd.
- GC Biopharma Corp.
- Grifols SA
- Kamada Ltd.
- Kedrion SpA
- LFB SA
- Meiji Holdings Co. Ltd.
- Octapharma AG
- Pfizer Inc.
- Sanquin
- SK Plasma Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
